TickerFactsScreenerDevelopers

Emmaus Life Sciences, Inc. (EMMA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: -$1.11M2010: -$4.20M2011: -$11.42M2012: -$13.07M2013: -$2.16M2014: -$1.76M2015: -$4.84M2016: -$1.06M2017: $18.29M2018: -$21.71M2019: -$11.05M2020: -$5.16M2021: -$21.45M2022: -$34.09M2023: -$47.76M2024: -$56.48M2025: -$63.61M-$63.61M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$63.61M-12.6%
2024-$56.48M-18.3%
2023-$47.76M-40.1%
2022-$34.09M-58.9%
2021-$21.45M-315.9%
2020-$5.16M+53.3%
2019-$11.05M+49.1%
2018-$21.71M-218.7%
2017$18.29M+1818.0%
2016-$1.06M+78.0%
2015-$4.84M-174.6%
2014-$1.76M+18.4%
2013-$2.16M+83.5%
2012-$13.07M-14.5%
2011-$11.42M-171.7%
2010-$4.20M-278.7%
2009-$1.11M—